`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`207202Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`MEMORANDUM
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`DATE:
`
`October 25, 2017
`
`TO:
`
`FROM:
`
`Administrative file for NDA 207202
`
`Brendan Muoio, Senior Regulatory Health Project Manager
`Division of Psychiatry Products, Office of Drug Evaluation I
`
`SUBJECT: Officer/Employee List for NDA 207202
`
`APPLICATION/DRUG:
`
`NDA 207202, Abilify MyCite, (aripiprazole tablets with sensor),
`oral tablets
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Atrakchi, Aisar
`Bouie, Teshara
`Fegley, Darren
`Holmes, Loretta
`Lee, Daniel
`Mathis, Mitchell
`Muoio, Brendan
`Nikhar, Bindi
`Quinn, Bradley
`Ralston, Luke
`Updegraff, Kimberly
`
`Reference ID: 4181717
`
`
`
`---------------------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically and this page is the manifestation of the electronic
`signature.
`---------------------------------------------------------------------------------------------------------
`/s/
`----------------------------------------------------
`
`BRENDAN MUOIO
`11/15/2017
`
`Reference ID: 4181717
`
`